In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications.
📊
Key Findings & Data:No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications.
💡
Conclusion & Impact:In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.
No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications. In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.
Özet
Mediatörler aracılığıyla ortaya çıktığı kabul edilen "no-reflow" fenomeni koroner arter girişimleri sonrasında hedef damarda TIMI 0 veya 1 akıma neden olmakta ve işlem komplikasyonlarını artırmaktadır. Bu yazıda ilginç olarak hedef damar dışında başka damarda da ortaya çıkan ve verapamil ile tedavi edilen bir "no-reflow" fenomeni olgusu sunulmaktadır.
KURŞAKLIOĞLU, H., İYİSOY, A., BARÇIN, C., KÖSE, S., DEMİRTAŞ, E. (2002). No-reflow phenomenon developed in non-target vessel during balloon angioplasty. MN Kardiyoloji, Cilt: 9 - Sayı: 4, 281–282. https://ajindex.com/articles/297708
References (6)
Abbo KM, Dooris M, Glazier S et al: Features and outcomes of no-reflow after percutaneous coronary interventions. Am J Cardiol 1995; 75:778-82
Piana RN, Paik GY, Moscucci M et al: Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994; 89:2514-8
Hayerizadeh BF, Marco J: Diagnosis and management of acute complications of coronary interventions In: Marco J, Serruys P, Biamino G, Fajadet J, Feyter P, Morice MC Eds. The Paris Course on Revascularization. Paris, 2001
Hillegas WB, Dean NA, Liao L, Rhinehart RG, Myers PR: Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37:1335-43
Pomerantz RM, Kuntz RE, Diver DJ et al: Intracoronary verapamil for the treatment of distal microvascular spasm following PTCA. Cath Cardiovasc Diagn 1991; 24:283-8
Dillon WC, Hadian D, Ritchie ME: Refractory no-reflow successfully treated with local infusion of high dose adenosine and verapamil. Angiology 2001; 52:137-41